1 unknown, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
Follow abivertinib: new trials by email Literature Review of abivertinib trials Research Report on abivertinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation Abivertinib Maleate Capsules, Placebo Gefitinib Tablets, Gefitinib Tablets - Advanced Non-small Cell Lung Cancer | Phase 3 | Unknown | Hangzhou ACEA Pharmaceutical Research Co., Ltd. | 406 | 2019-03-01 | 2019-02-27 |
| A Study Comparing AC0010 and Chemotherapy in Patients With Advanced NSCLC Who Have Progressed Following Prior EGFR TKI Pemetrexed, Cisplatin 75mg/m2, AC0010 - NSCLC | Phase 3 | Withdrawn | Hangzhou ACEA Pharmaceutical Research Co., Ltd. | 2018-12-01 | 2019-02-04 |
Hangzhou ACEA Pharmaceutical Research Co., Ltd. (2)
China (2)
Yilong Wu, MD (1) · Yuankai Shi, MD. (1)